| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 3646 |
17:0-22:4 PC-d5|1-heptadecanoyl-2-docosatetraenoyl-sn-glycero(d5)-3-phosphocholine |
690 |
axc |
2023-04-10 |
| 3647 |
17:0 Lyso PC-d5|1-heptadecanoyl-2-hydroxy-sn-glycero(d5)-3-phosphocholine |
681 |
axc |
2023-04-10 |
| 3648 |
17:0-14:1 PC-d5|1-heptadecanoyl-2-myristoleoyl-sn-glycero(d5)-3-phosphocholine |
636 |
axc |
2023-04-10 |
| 3649 |
14:0 PC-d9|1,2-dimyristoyl-sn-glycero-3-phosphocholine-N,N,N-trimethyl-d9磷脂 |
600 |
axc |
2023-04-10 |
| 3650 |
14:0 PC-d63|1,2-dimyristoyl-d54-sn-glycero-3-phosphocholine-N,N,N-trimethyl-d9 |
650 |
axc |
2023-04-10 |
| 3651 |
16:0 PC-d4|1,2-dipalmitoyl-sn-glycero-3-phosphocholine-1,1,2,2-d4磷脂 |
674 |
axc |
2023-04-10 |
| 3652 |
16:0 PC-d62|1,2-dipalmitoyl-d62-sn-glycero-3-phosphocholine磷脂 |
672 |
axc |
2023-04-10 |
| 3653 |
16:0-d31-18:1 PC|1-palmitoyl-d31-2-oleoyl-sn-glycero-3-phosphocholine 磷脂 |
640 |
axc |
2023-04-10 |
| 3654 |
N3-PEG6-CH2COOH 880129-82-8 Azide-PEG6-CH2COOH PEG试剂 |
595 |
LYQ |
2023-04-10 |
| 3655 |
16:0-Pyr PC|1-hexadecanoyl-2-(1-pyrenedecanoyl)-sn-glycero-3-phosphatidylcholine|PC磷脂 |
1323 |
axc |
2023-04-10 |
| 3656 |
18:1(11-cis) PC|1,2-divaccenoyl -sn-glycero-3-phosphocholine|PC磷脂 |
618 |
axc |
2023-04-10 |
| 3657 |
16:1 (Δ9-Trans) PC|1,2-dipalmitelaidoyl-sn-glycero-3-phosphocholine|PC磷脂 |
695 |
axc |
2023-04-10 |
| 3658 |
18:1 (Δ9-Trans) PC|1,2-dielaidoyl-sn-glycero-3-phosphocholine|PC磷脂 |
1293 |
axc |
2023-04-10 |
| 3659 |
06:0 Lyso PC|1-hexanoyl-2-hydroxy-sn-glycero-3-phosphocholine 磷脂PC |
725 |
axc |
2023-04-07 |
| 3660 |
2-18:1 Lyso PC|1-hydroxy-2-oleoyl-sn-glycero-3-phosphocholine PC类磷脂 |
622 |
axc |
2023-04-07 |
| 3661 |
20:0 Lyso PC|1-arachidoyl-2-hydroxy-sn-glycero-3-phosphocholine PC类磷脂 |
594 |
axc |
2023-04-07 |
| 3662 |
N3-PEG4-SPA 944251-24-5 PEG修饰剂 |
630 |
LYQ |
2023-04-07 |
| 3663 |
聚偏二氟乙烯/聚丙烯腈海水淡化膜 ，聚偏二氟乙烯/共六氟丙烯海水淡化膜 |
702 |
zyl |
2023-04-06 |
| 3664 |
mPEG6-N3 1043884-49-6 PEG修饰剂 |
698 |
LYQ |
2023-04-06 |
| 3665 |
酶抑制剂靶点预测|药物靶点评估|化合物库定制 |
907 |
zyl |
2023-04-04 |
| 3666 |
细胞膜修饰脂质体/蛋白/聚合物纳米载体/磁性纳米粒子 |
624 |
zyl |
2023-04-04 |
| 3667 |
cas:90429-66-6 Tempol-d17,15N 活性氧簇 |
704 |
axc |
2023-04-04 |
| 3668 |
Topo I/COX-2-IN-2 活性氧抑制剂运输条件 |
660 |
axc |
2023-04-04 |
| 3669 |
CAS：2133360-04-8 Pomalidomide-NH-CO-PEG1-N3 PEG衍生物 |
693 |
LYQ |
2023-04-04 |
| 3670 |
PEG衍生物 Thalidomide-O-PEG4-N3 2380318-57-8 萨力多胺-O-四聚乙二醇-叠氮 |
650 |
LYQ |
2023-04-04 |
| 3671 |
cas:2402735-14-0 DPP-4-IN-3 抗氧化小分子 |
613 |
axc |
2023-04-04 |
| 3672 |
cas:38216-54-5 Aureusidin 抗氧化抑制剂 |
642 |
axc |
2023-04-03 |
| 3673 |
cas:121009-77-6 Simvastatin acid 分子量436.58 活性氧 |
610 |
axc |
2023-04-03 |
| 3674 |
Biotin-PEG6-OH 906099-89-6 小分子PEG |
619 |
LYQ |
2023-04-03 |
| 3675 |
1.计算机辅助药物设计-活性/药物筛选 |
738 |
zyl |
2023-04-03 |
| 3676 |
关于PEG制备方法的简单介绍 |
979 |
LYQ |
2023-03-31 |
| 3677 |
Reactive oxygen species（ROS）活性氧响应的新型阳离子共聚物 |
1082 |
zyl |
2023-03-30 |
| 3678 |
ROS浓度高低对细胞的影响，为什么要测ROS？ |
6568 |
zyl |
2023-03-30 |
| 3679 |
硫醇过氧化物酶在ROS信号传递中的作用 |
1164 |
zyl |
2023-03-30 |
| 3680 |
ROS活性氧有哪些检测方法？ |
1187 |
zyl |
2023-03-29 |
| 3681 |
活性氧Reactive Oxygen Species，ROS检测 |
674 |
zyl |
2023-03-29 |
| 3682 |
cas:916888-49-8 L-Acetyldopamine dimer-2 抗氧化抑制剂 |
671 |
axc |
2023-03-29 |
| 3683 |
cas:101314-97-0 Simvastatin hydroxy acid sodium辛伐他汀钠盐活性氧分子 |
755 |
axc |
2023-03-29 |
| 3684 |
Indirubin-3′-oxime Cas号：667463-82-3 Reactive Oxygen Species |
1067 |
LYQ |
2023-03-29 |
| 3685 |
cas:102841-46-3 Moracin P 桑辛素P 活性氧抑制剂 |
718 |
axc |
2023-03-29 |
| 3686 |
cas:109-57-9 Allylthiourea 烯丙基硫脲 活性氧抑制剂 |
712 |
axc |
2023-03-28 |
| 3687 |
cas:16724-03-1 2-Selenouracil 活性氧簇 |
582 |
axc |
2023-03-28 |
| 3688 |
cas:28282-25-9 β-Elemonic acid β-岚香酮酸 ROS小分子 |
652 |
axc |
2023-03-28 |
| 3689 |
cas:113170-55-1 L-Ascorbic acid 2-phosphate magnesium 维生素C磷酸酯镁抗氧化抑制剂 |
855 |
axc |
2023-03-28 |
| 3690 |
cas:2031170-96-2 HKOH-1 抗氧化抑制剂 |
615 |
axc |
2023-03-28 |
齐岳微信公众号
官方微信
库存查询